http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0065356-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0beb679cad83d5c20bd2995f628efa5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate | 2000-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58bd85b15ca535410288919ec1080cfd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb9bcac3e69d2800646492584a0dca5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5912b9efbccf47f6be912096ec62a5b |
| publicationDate | 2000-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0065356-A1 |
| titleOfInvention | Assay for hiv-1 infectivity |
| abstract | The present invention relates to cells which have improved receptivity to viruses which are capable of infecting them. Receptivity to such viruses is improved by selecting cells from a population which express the receptor(s) that enable a virus to attach to the cell and gain entry into it. Any combination of viruses and host cell lines can be used. In a preferred embodiment, the present invention relates to improving receptivity or infectivity of a cell line which can be infected with an immunodeficiency virus, such as HIV-1. Especially preferred embodiments of the invention relate to methods of improving (or assaying for) the infectivity for HIV-1 in a HIV-1 receptive cell line, preferably a continuous cell line transformed with DNAs coding for expressible CD4 and expressible HIV-1 coreceptor, comprising, in any effective order, a) isolating the cells expressing CD4 and an HIV-1 coreceptor on their cell surface; b) contacting the isolated cells with HIV-1 under conditions effective for the HIV-1 to infect the cells; and c) detecting the number of cells infected with HIV-1, thereby assaying for infectivity of HIV-1. This method facilitates the measurement of true infectivity and infectivity reduction values by quantifying the percentage of infected cells in the population of specific cells capable of being infected by virus, rather than in a population of mixed cells, only some which are capable of being infected. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6797462-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0227321-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943297-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6727060-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2333543-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7718356-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0227321-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7294458-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7344830-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709191-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119339-B2 |
| priorityDate | 1999-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.